Splicing targeting drugs highlight intron retention as an actionable vulnerability in advanced prostate cancer.

Chiara NaroAmbra AntonioniVanessa MediciCinzia CaggianoAriane JollyPierre de la GrangePamela BielliMaria Paola ParonettoClaudio Sette

Published in: Journal of experimental & clinical cancer research : CR (2024)

Our study uncovers intron retention as an actionable vulnerability for advanced PC, which may be exploited to improve therapeutic management of this currently incurable disease.

Keyphrases

prostate cancer
climate change
radical prostatectomy